Stock 300363 PORTON PHARMA SOLUTIONS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
17.41 CNY -3.12% Intraday chart for Porton Pharma Solutions Ltd. +3.57% -30.78%
04-26 Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-26 Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
CI
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.
CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.
CI
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.
CI
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.
CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023
CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022
CI
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders
MT
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022
CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility
MT
China’s Porton to set up biotech park in Slovenia’s Menges
AQ
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300363 Stock
  4. News Porton Pharma Solutions Ltd.